Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

被引:45
作者
Zarka, Jabra [1 ]
Short, Nicholas J. [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Issa, Ghayas C. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
AML; nucleophosmin (NPM1); gene expression; targeted therapies; TUMOR-SUPPRESSOR PROTEIN; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; GENE-EXPRESSION PROFILE; NPM1; MUTATIONS; CLONAL HEMATOPOIESIS; MUTANT NUCLEOPHOSMIN; RIBOSOME BIOGENESIS; RETINOIC ACID; CYTOPLASMIC NUCLEOPHOSMIN;
D O I
10.3390/genes11060649
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein involved in ribosome biogenesis, the maintenance of genomic integrity and the regulation of the ARF-p53 tumor-suppressor pathway among multiple other functions. Mutations in the corresponding gene cause a cytoplasmic dislocation of the NPM1 protein. These mutations are unique to acute myeloid leukemia (AML), a disease characterized by clonal expansion, impaired differentiation and the proliferation of myeloid cells in the bone marrow. Despite our improved understanding ofNPM1mutations and their consequences, the underlying leukemia pathogenesis is still unclear. Recent studies that focused on dysregulated gene expression in AML with mutatedNPM1have shed more light into these mechanisms. In this article, we review the current evidence on normal functions of NPM1 and aberrant functioning in AML, and highlight investigational strategies targeting these mutations.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [31] Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia
    Patel, Jay L.
    Schumacher, Jonathan A.
    Frizzell, Kimberly
    Sorrells, Shelly
    Shen, Wei
    Clayton, Adam
    Jattani, Rakhi
    Kelley, Todd W.
    LEUKEMIA RESEARCH, 2017, 56 : 7 - 12
  • [32] IDH2 mutations in acute myeloid leukemia
    Babakhanlou, Rodrick
    DiNardo, Courtney
    Borthakur, Gautam
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1733 - 1741
  • [33] Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
    Taussig, David C.
    Vargaftig, Jacques
    Miraki-Moud, Farideh
    Griessinger, Emmanuel
    Sharrock, Kirsty
    Luke, Tina
    Lillington, Debra
    Oakervee, Heather
    Cavenagh, Jamie
    Agrawal, Samir G.
    Lister, T. Andrew
    Gribben, John G.
    Bonnet, Dominique
    BLOOD, 2010, 115 (10) : 1976 - 1984
  • [34] Dactinomycin in acute myeloid leukemia with NPM1 mutations
    Beziat, Guillaume
    Tavitian, Suzanne
    Bertoli, Sarah
    Huguet, Francoise
    Largeaud, Laetitia
    Luquet, Isabelle
    Vergez, Francois
    Rieu, Jean-Baptiste
    Bories, Pierre
    Delabesse, Eric
    Recher, Christian
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (03) : 302 - 307
  • [35] Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia
    Rampal, Raajit
    Figueroa, Maria E.
    HAEMATOLOGICA, 2016, 101 (06) : 672 - 679
  • [36] Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition
    Greiner, Jochen
    Hofmann, Susanne
    Schmitt, Michael
    Goetz, Marlies
    Wiesneth, Markus
    Schrezenmeier, Hubert
    Bunjes, Donald
    Doehner, Hartmut
    Bullinger, Lars
    HAEMATOLOGICA, 2017, 102 (12) : 499 - 501
  • [37] Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia
    Ziai, James M.
    Siddon, Alexa J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (04) : 539 - 554
  • [38] The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain
    La Manna, Sara
    Scognamiglio, Pasqualina Liana
    Roviello, Valentina
    Borbone, Fabio
    Florio, Daniele
    Di Natale, Concetta
    Bigi, Alessandra
    Cecchi, Cristina
    Cascella, Roberta
    Giannini, Cinzia
    Sibillano, Teresa
    Novellino, Ettore
    Marasco, Daniela
    FEBS JOURNAL, 2019, 286 (12) : 2311 - 2328
  • [39] Acute myeloid leukemia
    Doehner, K.
    Paschka, P.
    Doehner, H.
    INTERNIST, 2015, 56 (04): : 354 - 363
  • [40] Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia
    Shi, Yuye
    Xue, Yuhao
    Wang, Chunling
    Yu, Liang
    HEMATOLOGY, 2022, 27 (01) : 609 - 619